SCHEMBL7985463

SCHEMBL7985463

CN(Cc1nc2ncn(Cc3ccccc3)c2c(=O)[nH]1)C(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 2/20 0.49
KMT2A Q03164 1/20 0.46
HTR2C P28335 1/20 0.44
SLC6A4 P31645 1/20 0.44
MCL1 Q07820 1/20 0.40
CACNA1G O43497 1/20 0.39
CACNA1B Q00975 1/20 0.39
CACNA1C Q13936 1/20 0.39
PNP P00491 2/20 0.39
PARN O95453 1/20 0.39
CNOT7 Q9UIV1 1/20 0.39
GAA P10253 1/20 0.38
BRD4 O60885 1/20 0.38
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987946 0.92 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7988125 0.91 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7992290 0.91 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7988916 0.91 HPGD (0.50) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7974303 0.91 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7991611 0.91 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7974183 0.90 HPGD (0.51) HPGDSMN1; SMN2ALDH1A1KMT2AMCL1
SCHEMBL7985320 0.89 LMNA (0.47) HPGDSMN1; SMN2ALDH1A1HTR2CSLC6A4
SCHEMBL7974033 0.89 HPGD (0.49) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7988933 0.89 GAA (0.44) HPGDSMN1; SMN2ALDH1A1HTR2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed